<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1153</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2023-31-1-16-19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>The rare diseases and orphan medications: Placement in health care of the Russian Federation</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Komarov</surname><given-names>I. A.</given-names></name><bio></bio><email>iliya_komarov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">N. A. Semashko National Research Institute of Public Health</aff><pub-date date-type="epub" iso-8601-date="2023-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2023</year></pub-date><volume>31</volume><issue>1</issue><fpage>16</fpage><lpage>19</lpage><history><pub-date date-type="received" iso-8601-date="2023-02-19"><day>19</day><month>02</month><year>2023</year></pub-date></history><permissions><copyright-statement>Copyright © 2023,</copyright-statement><copyright-year>2023</copyright-year></permissions><abstract>The rare diseases are characterized both by relatively small prevalence in population and complexity of medical care support of patients. In this particular case, the legal regulation of medical care takes its particular placement in health care. The uniqueness of rare diseases requires development of special normative legal acts, definitions and treating approaches. One of such approaches are orphan drugs that also are unique, complicated in development and require special legislative regulation. The article presents corresponding legislative terminology in modern Russian health care, actual listings of rare diseases and orphan drugs. The directions to improve current terminology and normative legal regulation are proposed.</abstract><kwd-group xml:lang="en"><kwd>public health</kwd><kwd>health care</kwd><kwd>rare diseases</kwd><kwd>orphan drugs</kwd><kwd>listing</kwd><kwd>medical care</kwd><kwd>patient</kwd><kwd>legislation</kwd><kwd>normative legal regulation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>общественное здоровье</kwd><kwd>здравоохранение</kwd><kwd>редкие заболевания</kwd><kwd>орфанные лекарственные препараты</kwd><kwd>перечень</kwd><kwd>медицинская помощь</kwd><kwd>пациент</kwd><kwd>законодательство</kwd><kwd>нормативно-правовое регулирование</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Taruscio D., Vittozzi L., Stefanov R. National plans and strategies on rare diseases in Europe. Adv. Exper. Med. Biol. 2010;(686):475-91.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Miller K. L., Lanthier M. Investigating the landscape of US orphan product approvals. Orphan. J. Rare Dis. 2018;183(13):1-8.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Соколов А. А., Волгина С. Я., Нагибин О. А. Анализ оказания специализированной медицинской помощи пациентам с редкими заболеваниями. Проблемы стандартизации в здравоохранении. 2019;7(8):51-62.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Соколов А. А., Александрова О. Ю., Комаров И. А. Проблемы оказания высокотехнологичной медицинской помощи пациентам, страдающим редкими заболеваниями. Проблемы стандартизации в здравоохранении. 2019;7(8):63-72.</mixed-citation></ref></ref-list></back></article>
